Compounds that are antibacterial and can inhibit efflux processes of bacteria could have potential to treat infections due to multidrug-resistant strains.
Funding:TheHeptagonFundandUnionLifeSciencesfundedthis work. Competing interests: None declared. Ethical approval: Not required.